StayCurrentMD · Biopsy Diagnosis of Hirschsprung's Disease Using a Single Excisional Biopsy Based on the Anorectal Line
Article1 min read·Published May 2023Older

Biopsy Diagnosis of Hirschsprung's Disease Using a Single Excisional Biopsy Based on the Anorectal Line

dx.doi.org shows its articles on its own site.

Read the article on dx.doi.org ↗

Article · May 2023 · 1 min read

In brief

In brief

This study validates a streamlined biopsy protocol for diagnosing Hirschsprung's disease using the anorectal line as an anatomic landmark. A single excisional biopsy above the anorectal line accurately identifies normal ganglion cells or aganglionosis, with second-level biopsy reserved only for hypoganglionic cases to distinguish physiologic from pathologic variants.

  • Single excisional biopsy just above the anorectal line accurately diagnoses normoganglionosis (47%) and aganglionosis (47%) in suspected HD.
  • Hypoganglionosis (5.6% of cases) requires second-level biopsy to distinguish physiologic from pathologic variants requiring pull-through.
  • Pathologic hypoganglionosis shows colon caliber change and severe obstructive symptoms, warranting definitive surgical intervention.
  • The anorectal line serves as an objective anatomic landmark, eliminating need for routine two-level biopsies in most HD diagnostic workups.
  • Conservative management is appropriate for physiologic hypoganglionosis with normal second-level biopsy; all achieved regular defecation.

Written by the GCMD Library team from the article.

Introduction A biopsy protocol for diagnosing Hirschsprung's disease (HD) in children using the anorectal line (ARL). Materials and Methods The ARL was adopted for diagnosing HD in 2016 using two excisional submucosal rectal biopsies performed at different levels, sequentially; the first just above the ARL and the second, further proximal (2-ARL). Currently, only the first-level biopsy is performed (1-ARL) and examined intraoperatively. Management was observation if normoganglionic, pull-through if aganglionic, and a second-level biopsy if hypoganglionic. Hypoganglionosis was considered physiologic if the second-level biopsy was normoganglionic and pathologic if hypoganglionic. Colon caliber change and bowel obstructive symptoms reflect the severity of hypoganglionosis. Results For 2-ARL (n = 54), results were: normoganglionosis (n = 31/54; 57.4%), aganglionosis (n = 19/54; 35.2%), and hypoganglionosis (n = 4/54; 7.4%); physiologic (n = 3/54; 5.6%) and pathologic (n = 1/54; 1.9%). Normoganglionosis and aganglionosis were always duplicated in 2-ARL (kappa = 1.0). For 1-ARL (n = 36), results were: normoganglionosis (n = 17/36; 47.2%), aganglionosis (n = 17/36; 47.2%), and hypoganglionosis (n = 2/36; 5.6%). Second-level biopsies were normoganglionic (physiologic: n = 1) and hypoganglionic (pathologic: n = 1). All normoganglionic cases, except one, resolved conservatively. All aganglionic cases had pull-through with HD confirmed on histopathology. Both pathologic hypoganglionic cases had caliber change and severe obstructive symptoms as definitive indications for pull-through with hypoganglionosis of the entire rectum confirmed on histopathology. Physiologic hypoganglionic cases were observed and currently have regular defecation. Conclusion Because the ARL is an objective functional, neurologic, and anatomic demarcation, normoganglionosis and aganglionosis can be diagnosed accurately with a single excisional biopsy. Only hypoganglionosis requires a second-level biopsy.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →